Privia Health Group (PRVA) Projected to Post Earnings on Thursday

Privia Health Group (NASDAQ:PRVA) is anticipated to issue its Q4 2025 results before the market opens on Thursday, February 26th. Analysts expect the company to announce earnings of $0.04 per share and revenue of $516.6090 million for the quarter. Individuals can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Thursday, February 26, 2026 at 8:00 AM ET.

Privia Health Group Stock Down 1.4%

NASDAQ PRVA opened at $21.78 on Thursday. The firm has a 50-day moving average price of $23.29 and a two-hundred day moving average price of $23.35. Privia Health Group has a 12-month low of $18.77 and a 12-month high of $26.51. The company has a market capitalization of $2.68 billion, a P/E ratio of 167.55, a P/E/G ratio of 1.55 and a beta of 0.83.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on PRVA. Citigroup reissued a “market outperform” rating on shares of Privia Health Group in a research report on Tuesday, January 6th. Citizens Jmp upped their target price on Privia Health Group from $30.00 to $31.00 and gave the company a “market outperform” rating in a research report on Friday, November 7th. Truist Financial reissued a “buy” rating and set a $31.00 target price (up from $30.00) on shares of Privia Health Group in a report on Monday, November 10th. Royal Bank Of Canada assumed coverage on Privia Health Group in a research report on Friday, January 9th. They issued an “outperform” rating and a $31.00 price target on the stock. Finally, JPMorgan Chase & Co. upped their price objective on shares of Privia Health Group from $32.00 to $33.00 and gave the stock an “overweight” rating in a research report on Thursday, November 13th. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $30.54.

Insider Buying and Selling at Privia Health Group

In other news, CFO David Mountcastle sold 23,887 shares of the stock in a transaction dated Friday, December 12th. The shares were sold at an average price of $25.03, for a total value of $597,891.61. Following the completion of the transaction, the chief financial officer owned 172,909 shares of the company’s stock, valued at approximately $4,327,912.27. This represents a 12.14% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Matthew Shawn Morris sold 13,647 shares of the firm’s stock in a transaction that occurred on Friday, December 12th. The shares were sold at an average price of $25.01, for a total transaction of $341,311.47. Following the completion of the sale, the director owned 68,188 shares in the company, valued at approximately $1,705,381.88. The trade was a 16.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 10.70% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Privia Health Group

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Vanguard Personalized Indexing Management LLC grew its stake in shares of Privia Health Group by 5.9% during the fourth quarter. Vanguard Personalized Indexing Management LLC now owns 16,250 shares of the company’s stock worth $385,000 after buying an additional 903 shares during the last quarter. Schroder Investment Management Group boosted its holdings in shares of Privia Health Group by 0.8% during the 4th quarter. Schroder Investment Management Group now owns 140,038 shares of the company’s stock valued at $3,341,000 after acquiring an additional 1,123 shares in the last quarter. Bradley Foster & Sargent Inc. CT grew its position in Privia Health Group by 3.3% during the 4th quarter. Bradley Foster & Sargent Inc. CT now owns 37,688 shares of the company’s stock worth $894,000 after acquiring an additional 1,192 shares during the last quarter. Canada Pension Plan Investment Board increased its holdings in Privia Health Group by 48.0% in the 2nd quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock worth $85,000 after purchasing an additional 1,200 shares in the last quarter. Finally, Natixis Advisors LLC raised its position in Privia Health Group by 6.4% in the fourth quarter. Natixis Advisors LLC now owns 20,352 shares of the company’s stock valued at $483,000 after purchasing an additional 1,221 shares during the last quarter. Institutional investors own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.